NORDTREAT: a randomised, multicentre, biomarker-strategy design, open-label, controlled trial of top-down versus clinical management in newly diagnosed IBD.
Saved in:
| Title: | NORDTREAT: a randomised, multicentre, biomarker-strategy design, open-label, controlled trial of top-down versus clinical management in newly diagnosed IBD. |
|---|---|
| Authors: | Bergemalm, D.1, Füchtbauer, D.2, Rejller, M.3, Davíðsdóttir, L.4, Fejrskov, A.2, Hedin, C. R.5, Bache-WiigMathisen, C.6, Hupperz-Hauss, G.7, Carstens, A.8, Kristensen, V.6, Hjortswang, H.9, Aabrekk, T. B.10, Carlson, M.11, Frigstad, S. O.12, Söderholm, J. D.13, Christensen, R.14, Andersen, V. C.15, Repsilber, D.16, Kjeldsen, J.17, Høivik, M.6 |
| Source: | Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pi8-i9. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
